Cheryl Cohen sold $851k of IBRX
director at ImmunityBio, Inc.. 81,056 shares at an average of $10.50, traded Oct 2, 2026, filed Oct 6, 2026.
Score components
- +15RoleDirector
- +23Trade size$851k at market
- +10Share of holdings soldSold 45% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001326110-26-000084, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | MOption exercise Common Stock10b5-1 | +55,979 | $2.98 | $167k | 181,365 | 7 d ago |
| Oct 2, 2026 | SOpen-market sale Common Stock10b5-1 | -81,056 | $10.50 | $851k | 100,309 | 7 d ago |
| Oct 2, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -55,979 | $0.00 | $0 | 55,979 | 7 d ago |
Related signals
Other insiders at ImmunityBio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 16Weak | ImmunityBio, Inc. | Barry J. Simon director | $269k 25,000 shares | -1% | |
| 7Weak | ImmunityBio, Inc. | Barry J. Simon director | $197k 25,000 shares | -1% | |
| 6Weak | ImmunityBio, Inc. | Barry J. Simon director | $165k 23,033 shares | -1% | |
| 27Weak | ImmunityBio, Inc. | Barry J. Simon director | $901k 75,000 shares | -3% | |
| 13Weak | ImmunityBio, Inc. | Barry J. Simon director | $1.8M 175,000 shares | -6% | |
| 21Weak | ImmunityBio, Inc. | Christobel Selecky director | $250k 25,000 shares | -100% | |
| 28Weak | ImmunityBio, Inc. | Barry J. Simon director | $1.1M 151,967 shares | -5% | |
| 25Weak | ImmunityBio, Inc. | Christobel Selecky director | $438k 75,000 shares | -150% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.